Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors — Final Report

BACKGROUND Ebola virus has been detected in the semen of men after their recovery from Ebola virus disease (EVD). We report the presence of Ebola virus RNA in semen in a cohort of survivors of EVD in Sierra Leone. METHODS We enrolled a convenience sample of 220 adult male survivors of EVD in Sierra Leone, at various times after discharge from an Ebola treatment unit (ETU), in two phases (100 participants were in phase 1, and 120 in phase 2). Semen specimens obtained at baseline were tested by means of a quantitative reverse‐transcriptase–polymerase‐chain‐reaction (RT‐PCR) assay with the use of the target sequences of NP and VP40 (in phase 1) or NP and GP (in phase 2). This study did not evaluate directly the risk of sexual transmission of EVD. RESULTS Of 210 participants who provided an initial semen specimen for analysis, 57 (27%) had positive results on quantitative RT‐PCR. Ebola virus RNA was detected in the semen of all 7 men with a specimen obtained within 3 months after ETU discharge, in 26 of 42 (62%) with a specimen obtained at 4 to 6 months, in 15 of 60 (25%) with a specimen obtained at 7 to 9 months, in 4 of 26 (15%) with a specimen obtained at 10 to 12 months, in 4 of 38 (11%) with a specimen obtained at 13 to 15 months, in 1 of 25 (4%) with a specimen obtained at 16 to 18 months, and in no men with a specimen obtained at 19 months or later. Among the 46 participants with a positive result in phase 1, the median baseline cycle‐threshold values (higher values indicate lower RNA values) for the NP and VP40 targets were lower within 3 months after ETU discharge (32.4 and 31.3, respectively; in 7 men) than at 4 to 6 months (34.3 and 33.1; in 25), at 7 to 9 months (37.4 and 36.6; in 13), and at 10 to 12 months (37.7 and 36.9; in 1). In phase 2, a total of 11 participants had positive results for NP and GP targets (samples obtained at 4.1 to 15.7 months after ETU discharge); cycle‐threshold values ranged from 32.7 to 38.0 for NP and from 31.1 to 37.7 for GP. CONCLUSIONS These data showed the long‐term presence of Ebola virus RNA in semen and declining persistence with increasing time after ETU discharge. (Funded by the World Health Organization and others.)

[1]  P. Formenty,et al.  Implementation of a study to examine the persistence of Ebola virus in the body fluids of Ebola virus disease survivors in Sierra Leone: Methodology and lessons learned , 2017, PLoS neglected tropical diseases.

[2]  Development of risk reduction behavioral counseling for Ebola virus disease survivors enrolled in the Sierra Leone Ebola Virus Persistence Study, 2015-2016 , 2017, PLoS neglected tropical diseases.

[3]  Thi Huyen Tram Nguyen,et al.  Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study. , 2017, The Lancet. Global health.

[4]  Timothy D. Flietstra,et al.  Ebola Virus Disease Diagnostics, Sierra Leone: Analysis of Real-time Reverse Transcription-Polymerase Chain Reaction Values for Clinical Blood and Oral Swab Specimens. , 2016, The Journal of infectious diseases.

[5]  Desmond E. Williams,et al.  Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data. , 2016, The Lancet. Global health.

[6]  Ian Goodfellow,et al.  Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  V. Lee,et al.  Psychological Distress among Ebola Survivors Discharged from an Ebola Treatment Unit in Monrovia, Liberia – A Qualitative Study , 2016, Front. Public Health.

[8]  Jay B. Varkey,et al.  Ebola Virus Persistence in Semen of Male Survivors. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Xiao-Ping Dong,et al.  Detection and Analysis of Ebola Virus in Sierra Leone-China Friendship Biosafety Laboratory from March 11 to April 20, 2015. , 2016, Biomedical and environmental sciences : BES.

[10]  J. Eaton,et al.  Psychosocial effects of an Ebola outbreak at individual, community and international levels , 2016, Bulletin of the World Health Organization.

[11]  P. Formenty,et al.  Systematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendations , 2016, BMJ Open.

[12]  Z. Yoti,et al.  Epidemiology and risk factors for Ebola virus disease in Sierra Leone-23 May 2014 to 31 January 2015. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Possible Sexual Transmission of Ebola Virus — Liberia, 2015 , 2015, MMWR. Morbidity and mortality weekly report.

[14]  A. McElroy,et al.  Relationship Between Ebola Virus Real-Time Quantitative Polymerase Chain Reaction-Based Threshold Cycle Value and Virus Isolation From Human Plasma. , 2015, The Journal of infectious diseases.

[15]  M. Addo,et al.  Severe Ebola virus infection complicated by gram-negative septicemia. , 2015, The New England journal of medicine.

[16]  F. Syed,et al.  A case of iced-tea nephropathy. , 2015, The New England journal of medicine.

[17]  K. Rogstad,et al.  Ebola virus as a sexually transmitted infection , 2015, Current opinion in infectious diseases.

[18]  Seung Hee Lee-Kwan,et al.  Support Services for Survivors of Ebola Virus Disease — Sierra Leone, 2014 , 2014, MMWR. Morbidity and mortality weekly report.

[19]  S. Dowell,et al.  Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. , 2007, The Journal of infectious diseases.

[20]  Stuart T. Nichol,et al.  Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome , 2004, Journal of Virology.

[21]  J Bertolli,et al.  Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. , 1999, The Journal of infectious diseases.

[22]  S. Dowell,et al.  Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. , 1999, The Journal of infectious diseases.

[23]  A. Sanchez,et al.  Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. , 1999, The Journal of infectious diseases.

[24]  G. Lloyd,et al.  A case of Ebola virus infection. , 1977, British medical journal.

[25]  G. Martini,et al.  [Spermatogenic transmission of the "Marburg virus". (Causes of "Marburg simian disease")]. , 1968, Klinische Wochenschrift.